StonvexLoading…
StonvexStonvexStonvexCore line items from PRPH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $3.56M | $2.68M | $1.43M | $6.77M |
Operating Income | $-12.32M | $-7.56M | $-3.66M | $-38.63M |
Net Income | $-7.34M | $-506.00K | $3.97M | $-53.36M |
EPS (Diluted) | $-0.19 | $-0.01 | $0.11 | $-2.61 |
Total Assets | $65.70M | $42.04M | $50.11M | $63.20M |
Total Liabilities | $58.84M | $30.61M | $34.99M | $55.85M |
Cash & Equivalents | $405.00K | $169.00K | $88.00K | $678.00K |
Free Cash Flow OCF − CapEx | $-7.11M | $-3.63M | $-3.38M | $-18.44M |
Shares Outstanding | 41.54M | 41.54M | 41.54M | 29.87M |